Finance

Lists
IMM:LON
ImmuPharma PLC
GBX 2.60
0.00%
(0.00) 1D
Nov 16, 4:35:23 PM UTC  ·   GBX
All symbols
SymbolPriceChange% Change
Generating top insights for IMM...
Mkt. cap
16.26M
Avg. vol.
3.34M
Volume
0.00
52-wk high
GBX 11.00
52-wk low
GBX 2.50
EPS
-GBX 0.01
Shares outstanding
623.91M
No. of employees
7
Mkt. cap
16.26M
Avg. vol.
3.34M
Volume
0.00
52-wk high
GBX 11.00
52-wk low
GBX 2.50
EPS
-GBX 0.01
Shares outstanding
623.91M
No. of employees
7
News stories
From web sources and news partners
About ImmuPharma PLC
CEO-
Employees7
Founded1999
HeadquartersLondon, England, United Kingdom
SectorHealth Care
IndustryPharmaceutical industry
Previous reportsAll values in GBP
Loading Previous Earnings...
Revenue
Net income
All values in GBP
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Revenue
-
-
-
-
Cost of goods sold
-
-
-
-
Cost of revenue
-
-
-
-
Research and development expenses
328.10K
328.10K
295.52K
295.52K
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
298.97K
298.97K
217.49K
217.49K
Operating expense
652.16K
652.16K
534.07K
534.07K
Total operating expenses
652.16K
652.16K
534.07K
534.07K
Operating income
-652.16K
-652.16K
-534.07K
-534.07K
Other non operating income
184.07K
184.07K
-
-
EBT including unusual items
-111.44K
-111.44K
-2.35M
-2.35M
EBT excluding unusual items
-111.44K
-111.44K
-2.35M
-2.35M
Income tax expense
-127.05K
-127.05K
-
-
Effective tax rate
114.00%
114.00%
-
-
Other operating expenses
-1.34K
-1.34K
-
-
Net income
15.61K
15.61K
-2.35M
-2.35M
Net profit margin
-
-
-
-
Earnings per share
-
-
-
-
Interest and investment income
367.37K
367.37K
1.78K
1.78K
Interest expense
-9.14K
-9.14K
-1.82M
-1.82M
Net interest expenses
358.23K
358.23K
-1.82M
-1.82M
Depreciation and amortization charges
-
-
-
-
EBITDA
-648.78K
-648.78K
-533.82K
-533.82K
Gain or loss from assets sale
-
-
-
-
Upcoming events
AI content may include mistakes. Learn more
Google apps